An Open-labeled Pilot Study to Determine the Efficacy of an E2//Nomegestrol Acetate (E2/NOMAC)Combination Oral Contraceptive (COC) in the Management of Heavy Menstrual Bleeding (HMB)
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Estradiol/nomegestrol (Primary)
- Indications Menorrhagia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Nov 2014 Planned End Date changed from 1 Dec 2013 to 1 Aug 2015, according to ClinicalTrials.gov record.
- 18 Nov 2014 Planned primary completion date changed from 1 Dec 2013 to 1 Apr 2015, according to ClinicalTrials.gov record.